atractylenolide iii has been researched along with Angiogenesis, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, R; Fu, J; Ke, X; Liu, T; Lu, H; Ma, J; Wang, S | 1 |
1 other study(ies) available for atractylenolide iii and Angiogenesis, Pathologic
Article | Year |
---|---|
The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Atractylodes; Bone Morphogenetic Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Core Binding Factor Alpha 1 Subunit; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Lactones; Male; Matrix Metalloproteinases; Neovascularization, Pathologic; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2015 |